Tecson, Vrianna L.

HRN: 28-93-49  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/01/2026
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
05/01/2026
05/08/2026
IV
45mg
Q24hours
T/c Neonatal Sepsis
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Bloodstream    Compliance to guidelines: